<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="lhon" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">lhon</book-part-id>
      <title-group>
        <title>Leber Hereditary Optic Neuropathy</title>
        <alt-title alt-title-type="alt-title">Synonyms: LHON, Leber's Disease, Leber's Optic Atrophy, Leber's Optic Neuropathy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yu-Wai-Man</surname>
            <given-names>Patrick</given-names>
          </name>
          <degrees>BMedSci, MBBS, PhD, FRCPath, FRCOphth</degrees>
          <xref ref-type="aff" rid="lhon.Tc.aff1"/>
          <xref ref-type="aff" rid="lhon.Tc.aff2"/>
          <email>patrick.yu-wai-man@ncl.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chinnery</surname>
            <given-names>Patrick F</given-names>
          </name>
          <degrees>BMedSci, MBBS, PhD, FRCPath, FRCP, FMedSci</degrees>
          <xref ref-type="aff" rid="lhon.Tc.aff3"/>
          <email>pfc25@medschl.cam.ac.uk</email>
        </contrib>
      </contrib-group>
      <aff id="lhon.Tc.aff1">Department of Ophthalmology &#x00026; Newcastle Wellcome Trust Centre for Mitochondrial Research<break/>Institute of Genetic Medicine, Centre for Life<break/>Newcastle University<break/>Newcastle upon Tyne, United Kingdom</aff>
      <aff id="lhon.Tc.aff2">NIHR Biomedical Research Centre at Moorfields Eye Hospital &#x00026; UCL Institute of Ophthalmology<break/>London, United Kingdom</aff>
      <aff id="lhon.Tc.aff3">Department of Clinical Neurosciences<break/>University of Cambridge<break/>Cambridge, United Kingdom</aff>
      <pub-history>
        <date date-type="created">
          <day>26</day>
          <month>10</month>
          <year>2000</year>
        </date>
        <date date-type="updated">
          <day>23</day>
          <month>6</month>
          <year>2016</year>
        </date>
        <date date-type="revised">
          <day>19</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="lca" document-type="chapter">Leber Congenital Amaurosis</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="legius" document-type="chapter">Legius Syndrome</related-object>
      <abstract id="lhon.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Leber hereditary optic neuropathy (LHON) is characterized by bilateral, painless, subacute visual failure that develops during young adult life. Males are four to five times more likely than females to be affected. Affected individuals are usually entirely asymptomatic until they develop visual blurring affecting the central visual field in one eye; similar symptoms appear in the other eye an average of two to three months later. In about 25% of cases, visual loss is bilateral at onset. Visual acuity is severely reduced to counting fingers or worse in the majority of cases, and visual field testing shows an enlarging dense central or centrocecal scotoma. After the acute phase, the optic discs become atrophic. Significant improvement in visual acuity is rare and most persons qualify for registration as legally blind (visual acuity &#x02264;20/200). Neurologic abnormalities such as postural tremor, peripheral neuropathy, nonspecific myopathy, and movement disorders have been reported to be more common in individuals with LHON than in the general population. Some individuals with LHON, usually women, may also develop a multiple sclerosis-like illness.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of LHON is established in a proband with bilateral, painless, subacute visual failure that develops during young adult life and/or by the identification of one of three common mtDNA pathogenic variants (m.3460G&#x0003e;A in <italic toggle="yes">MT-ND1</italic>, m.11778G&#x0003e;A in <italic toggle="yes">MT-ND4</italic>, or m.14484T&#x0003e;C in <italic toggle="yes">MT-ND6</italic>) on molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Management of affected individuals is largely supportive, with the provision of visual aids, help with occupational rehabilitation, and registration with the relevant social services. ECG may reveal a pre-excitation syndrome in individuals harboring a mtDNA LHON-causing pathogenic variant; referral to cardiology can be considered and treatment for symptomatic individuals is the same as that in the general population. A multidisciplinary approach for those affected individuals with extraocular neurologic features (ataxia, peripheral neuropathy, nonspecific myopathy, and movement disorders) should be considered to minimize the functional consequences of these complications.</p>
          <p><italic toggle="yes">Prevention of primary manifestations</italic>: Treatment for raised intraocular pressure in individuals who have a LHON-causing pathogenic variant.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid</italic>: Individuals harboring a mtDNA LHON-causing pathogenic variant should be strongly advised to moderate their alcohol intake and not to smoke. Avoiding exposure to other putative environmental triggers for visual loss, in particular industrial toxins and drugs with mitochondrial-toxic effects, also seems reasonable.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Leber hereditary optic neuropathy is caused by pathogenic variants in mtDNA and transmitted by mitochondrial (maternal) inheritance. Genetic counseling for LHON is complicated by the gender- and age-dependent penetrance of the primary mtDNA LHON-causing pathogenic variants. The mother of a proband usually has the mtDNA pathogenic variant and may or may not have symptoms. In most cases a history of visual loss affecting maternal relatives at a young age is present, but up to 40% of cases are simplex (i.e., occur in a single individual in a family). A male (affected or unaffected) with a primary LHON-causing mtDNA pathogenic variant cannot transmit the variant to any of his offspring. A female (affected or unaffected) with a primary LHON-causing mtDNA pathogenic variant transmits the variant to all of her offspring. Prenatal diagnosis for mitochondrial pathogenic variants is possible if the variant in a family is known; however, accurate interpretation of a positive prenatal test result is difficult because the mtDNA mutational load in amniocytes and chorionic villi may not correspond to that of other fetal or adult tissues, and the presence of the mtDNA pathogenic variant does not predict the occurrence of disease, age of onset, severity, or rate of disease progression.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="lhon.Diagnosis">
        <title>Diagnosis</title>
        <sec id="lhon.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Leber hereditary optic neuropathy (LHON) <bold>should be suspected</bold> in individuals with the following ophthalmologic, extraocular, neuroimaging, biochemical, and family history findings:</p>
          <p>
            <bold>Ophthalmologic</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Bilateral, painless subacute visual failure that develops during young adult life</p>
              <list list-type="bullet">
                <list-item>
                  <p>Visual acuity is severely reduced to counting fingers or worse in the majority of cases.</p>
                </list-item>
                <list-item>
                  <p>Visual field testing by kinetic or static perimetry shows an enlarging dense central or centrocecal scotoma.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Disk hyperemia, edema of the peripapillary retinal nerve fiber layer, retinal telangiectasia, and increased vascular tortuosity</p>
              <p>Note: Approximately 20% of affected individuals show no fundal abnormalities in the acute stage.</p>
            </list-item>
            <list-item>
              <p>Optic disc atrophy</p>
            </list-item>
            <list-item>
              <p>Electrophysiologic studies (pattern electroretinogram and visual evoked potentials) demonstrating optic nerve dysfunction and the absence of retinal disease</p>
            </list-item>
          </list>
          <p>
            <bold>Extraocular</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic abnormalities</p>
              <list list-type="bullet">
                <list-item>
                  <p>Postural tremor</p>
                </list-item>
                <list-item>
                  <p>Peripheral neuropathy</p>
                </list-item>
                <list-item>
                  <p>Movement disorders</p>
                </list-item>
                <list-item>
                  <p>Multiple sclerosis-like illness</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Nonspecific myopathy</p>
            </list-item>
            <list-item>
              <p>Cardiac arrhythmias</p>
            </list-item>
          </list>
          <p><bold>Neuroimaging.</bold> Magnetic resonance imaging (MRI) is often normal, but may reveal white matter lesions and/or a high signal within the optic nerves [<xref ref-type="bibr" rid="lhon.REF.matthews.2015.537">Matthews et al 2015</xref>].</p>
          <p><bold>Biochemical</bold> studies show respiratory chain defect that is more subtle than that seen in other mitochondrial genetic disorders. The <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material> pathogenic variant in <italic toggle="yes">MT-ND1</italic> is associated with the most severe biochemical phenotype (see <xref ref-type="table" rid="lhon.T.respiratory_chain_dysfunction_in">Table 1</xref>).</p>
          <table-wrap id="lhon.T.respiratory_chain_dysfunction_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Respiratory Chain Dysfunction in LHON</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_1">Mitochondrial DNA Variant</th>
                  <th id="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">In Vitro</th>
                  <th id="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">In Vivo</th>
                </tr>
                <tr>
                  <th headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2" id="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Complex I Activity</th>
                  <th headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2" id="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Respiratory Rate&#x000a0;<sup>1</sup></th>
                  <th headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_3" id="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">MRS&#x000a0;<sup>1</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material>
                  </td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">60%-80% less than controls</td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">30%-35%</td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_3 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material>
                  </td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">0%-50% less than controls</td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">30%-50%</td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_3 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">75%</td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material>
                  </td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">0%-65% less than controls</td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_2 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">10%-20%</td>
                  <td headers="hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_1_3 hd_h_lhon.T.respiratory_chain_dysfunction_in_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">50%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>See references in <xref ref-type="bibr" rid="lhon.REF.man.2002.162">Man et al [2002]</xref>.</p>
              </fn>
              <fn>
                <p>MRS = magnetic resonance spectroscopy</p>
              </fn>
              <fn id="lhon.TF.1.1">
                <label>1. </label>
                <p>% of decrease relative to controls</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Family history</bold> of similarly affected individuals is seen in up to 60% of probands. Note: Absence of a family history of LHON does not preclude the diagnosis.</p>
        </sec>
        <sec id="lhon.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of LHON <bold>is established</bold> in a proband with the ocular manifestations listed in <xref ref-type="sec" rid="lhon.Suggestive_Findings">Suggestive Findings</xref>
<bold>and/or</bold> by the identification of one of three common mtDNA pathogenic variants on molecular genetic testing (see <xref ref-type="table" rid="lhon.T.molecular_genetic_testing_used_in">Table 2</xref>).</p>
          <p>Molecular testing approaches can include <bold>targeted testing</bold>, a <bold>multi-gene panel</bold>, or <bold>complete mtDNA sequencing</bold>.</p>
          <p><bold>Targeted testing.</bold> Three common mtDNA pathogenic variants account for 90%-95% of LHON. Targeted analysis for one of these three variants should be performed first.</p>
          <list list-type="bullet">
            <list-item>
              <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material> in <italic toggle="yes">MT-ND1</italic></p>
            </list-item>
            <list-item>
              <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material> in <italic toggle="yes">MT-ND4</italic>, present in 70% of affected individuals of northern European descent and 90% of affected individuals of Asian descent [<xref ref-type="bibr" rid="lhon.REF.mackey.1996.481">Mackey et al 1996</xref>, <xref ref-type="bibr" rid="lhon.REF.mashima.1998.403">Mashima et al 1998</xref>, <xref ref-type="bibr" rid="lhon.REF.jia.2006.851">Jia et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material> in <italic toggle="yes">MT-ND6</italic>, commonly found among French Canadians due to a founder effect [<xref ref-type="bibr" rid="lhon.REF.mackey.1996.481">Mackey et al 1996</xref>, <xref ref-type="bibr" rid="lhon.REF.macmillan.1998.417">Macmillan et al 1998</xref>, <xref ref-type="bibr" rid="lhon.REF.chinnery.2001.235">Chinnery et al 2001</xref>, <xref ref-type="bibr" rid="lhon.REF.man.2003.333">Man et al 2003</xref>]</p>
            </list-item>
          </list>
          <p><bold>A multi-gene panel</bold> that includes the mitochondrial genes that encode subunits of NADH dehydrogenase, <italic toggle="yes">MT-ND1</italic>, <italic toggle="yes">MT-ND2</italic>, <italic toggle="yes">MT-ND4</italic>, <italic toggle="yes">MT-ND4L</italic>, <italic toggle="yes">MT-ND5</italic>, and <italic toggle="yes">MT-ND6</italic>, which are known to cause LHON (see <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">Table 5</inline-supplementary-material> [pdf]) and other genes of interest (see <xref ref-type="sec" rid="lhon.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and the sensitivity of multi-gene panels vary by laboratory and over time.</p>
          <p><bold>Complete mtDNA sequencing</bold> may be considered if use of targeted testing and/or a multi-gene panel did not identify a pathogenic variant, clinical suspicion remains high, and there is no evidence of paternal transmission.</p>
          <table-wrap id="lhon.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Leber Hereditary Optic Neuropathy (LHON)</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_2">Proportion of LHON Attributed to Pathogenic Variants in This Gene</th>
                  <th id="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detected by Test Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_1" valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Targeted analysis for pathogenic variants</th>
                  <th headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></th>
                  <th headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1"><italic toggle="yes">MT-ND4</italic>,<break/><italic toggle="yes">MT-ND6</italic>,<break/><italic toggle="yes">MT-ND1</italic></td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~90%&#x000a0;<sup>5,&#x000a0;6</sup></td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">See footnote 7</td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">90%&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>6</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Select mitochondrial genes</td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">~10%&#x000a0;<sup>6,&#x000a0;8</sup></td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1"/>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">10%&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_lhon.T.molecular_genetic_testing_used_in_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">None reported&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="lhon.TF.2.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="lhon" object-id="lhon.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="lhon.TF.2.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="lhon.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="lhon.TF.2.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="lhon.TF.2.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="lhon.TF.2.5">
                <label>5. </label>
                <p>
                  <xref ref-type="bibr" rid="lhon.REF.mackey.1996.481">Mackey et al [1996]</xref>
                </p>
              </fn>
              <fn id="lhon.TF.2.6">
                <label>6. </label>
                <p>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/foswiki/bin/view/MITOMAP/MutationsLHON">Mitomap</ext-link>
                </p>
              </fn>
              <fn id="lhon.TF.2.7">
                <label>7. </label>
                <p>The three most common pathogenic variants are: <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material> (<italic toggle="yes">MT-ND4</italic>), accounting for approximately 70% of cases among northern European populations [<xref ref-type="bibr" rid="lhon.REF.wallace.1988.1427">Wallace et al 1988</xref>, <xref ref-type="bibr" rid="lhon.REF.mackey.1996.481">Mackey et al 1996</xref>]; <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material> (<italic toggle="yes">MT-ND6</italic>), most common among French Canadians as a result of a founder effect [<xref ref-type="bibr" rid="lhon.REF.johns.1992a.1551">Johns et al 1992a</xref>, <xref ref-type="bibr" rid="lhon.REF.macmillan.1998.417">Macmillan et al 1998</xref>]; and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material> (<italic toggle="yes">MT-ND1</italic>) [<xref ref-type="bibr" rid="lhon.REF.howell.1992.443">Howell et al 1992</xref>].</p>
              </fn>
              <fn id="lhon.TF.2.8">
                <label>8. </label>
                <p>
                  <xref ref-type="bibr" rid="lhon.REF.achilli.2012.e42242">Achilli et al [2012]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Interpretation of test results.</bold> Heteroplasmy, a mixture of mutated and wild-type mtDNA in leukocytes, occurs in approximately 10%-15% of individuals with LHON [<xref ref-type="bibr" rid="lhon.REF.smith.1993.1486">Smith et al 1993</xref>, <xref ref-type="bibr" rid="lhon.REF.man.2003.333">Man et al 2003</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>Heteroplasmy does not influence the sensitivity of molecular genetic testing for LHON because affected individuals generally have more than 70% mutated mtDNA in leukocytes, which is easily detected by standard techniques.</p>
            </list-item>
            <list-item>
              <p>It is likely that the level of heteroplasmy may have a bearing on the risk of developing LHON in the asymptomatic individual and on the risk for transmission [<xref ref-type="bibr" rid="lhon.REF.chinnery.2001.235">Chinnery et al 2001</xref>]; however, no rigorous prospective studies have been performed to clarify this possibility.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="lhon.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="lhon.Clinical_Description">
          <title>Clinical Description</title>
          <p>Leber hereditary optic neuropathy (LHON) typically presents in young adults as bilateral, painless, subacute visual failure. The peak age of onset in LHON is in the second and third decades of life, with 95% of those who lose their vision doing so before age 50 years. Very rarely, individuals first manifest LHON in the seventh and eighth decades of life [<xref ref-type="bibr" rid="lhon.REF.dimitriadis.2014.158">Dimitriadis et al 2014</xref>]. Males are four to five times more likely to be affected than females, but neither gender nor mutational status significantly influences the timing and severity of the initial visual loss.</p>
          <p>In the <bold>presymptomatic phase</bold>, fundal abnormalities including peripapillary telangiectatic vessels and variable degrees of retinal nerve fiber layer edema have been previously documented; these can vary with time [<xref ref-type="bibr" rid="lhon.REF.nikoskelainen.1994.115">Nikoskelainen 1994</xref>]. Using optical coherence tomography imaging, thickening of the temporal retinal nerve fiber layer was confirmed in clinically unaffected individuals with a LHON-causing mtDNA pathogenic variant, providing further evidence that the papillomacular bundle is particularly vulnerable in LHON [<xref ref-type="bibr" rid="lhon.REF.savini.2005.127">Savini et al 2005</xref>]. On more detailed investigation, some individuals with a LHON-causing mtDNA pathogenic variant can also exhibit subtle impairment of optic nerve function including: (a) loss of color vision affecting mostly the red-green system, (b) reduced contrast sensitivity, and (c) subnormal electroretinogram and visual evoked potential [<xref ref-type="bibr" rid="lhon.REF.sadun.2006.51">Sadun et al 2006</xref>].</p>
          <p>Affected individuals are usually entirely asymptomatic until they develop visual blurring affecting the central visual field in one eye (<bold>acute phase</bold>); similar symptoms appear in the other eye an average of two to three months later, so that both eyes are affected in the majority of cases within six months. Unilateral optic nerve involvement in LHON is exceptionally rare; if it is present, another underlying pathologic process should be actively excluded. In about 25% of cases, visual loss is bilateral at onset. The most characteristic feature is an enlarging central or centrocecal scotoma and as the field defect increases in size and density, visual acuity deteriorates to the level of counting fingers or worse. Following the nadir, visual acuity may improve; such improvement is more likely in individuals with the <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material> pathogenic variant than in those with the <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material> or <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material> pathogenic variant (see <xref ref-type="sec" rid="lhon.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
          <p>Other positive prognostic factors have been identified including an earlier age of onset (&#x0003c;10 years), a subacute presentation with slow visual deterioration, and a relatively large optic disc [<xref ref-type="bibr" rid="lhon.REF.barboni.2006.5303">Barboni et al 2006</xref>, <xref ref-type="bibr" rid="lhon.REF.ramos.2009.1666">Ramos et al 2009</xref>].</p>
          <p>The <bold>atrophic phase</bold> is characterized by optic atrophy (which typically develops within six weeks of the onset of visual loss) and a dense central or centrocecal scotoma. Most persons remain severely visually impaired and are within the legal requirements for blind registration [<xref ref-type="bibr" rid="lhon.REF.kirkman.2009.3112">Kirkman et al 2009</xref>].</p>
          <p><bold>Other neurologic features associated with LHON.</bold> Some neurologic abnormalities (e.g., postural tremor, peripheral neuropathy, nonspecific myopathy, movement disorders, and Leigh syndrome) have been reported to be common in individuals with LHON [<xref ref-type="bibr" rid="lhon.REF.mcfarland.2007.911">McFarland et al 2007</xref>, <xref ref-type="bibr" rid="lhon.REF.martikainen.2016.668">Martikainen et al 2016</xref>].</p>
          <p>Some individuals with LHON, usually women, may develop a progressive multiple sclerosis (MS)-like illness. The pattern of visual loss in LHON-MS appears distinct from classic LHON, being marked by recurrent episodes of visual loss that can be associated with ocular pain, but with incomplete visual recovery and progression to legal blindness in half of all affected persons [<xref ref-type="bibr" rid="lhon.REF.pfeffer.2013.2073">Pfeffer et al 2013</xref>]. In addition to a severe bilateral optic neuropathy, these individuals manifest disseminated central nervous system demyelination, with characteristic periventricular white matter lesions and unmatched cerebrospinal fluid oligoclonal bands [<xref ref-type="bibr" rid="lhon.REF.bhatti.1999.28">Bhatti &#x00026; Newman 1999</xref>, <xref ref-type="bibr" rid="lhon.REF.horv_th.2000.65">Horv&#x000e1;th et al 2000</xref>, <xref ref-type="bibr" rid="lhon.REF.palace.2009.24">Palace 2009</xref>].</p>
          <p><bold>Cardiac conduction defects and LHON.</bold> A Finnish study showed an increased incidence of cardiac arrhythmias secondary to accessory pathways in association with LHON [<xref ref-type="bibr" rid="lhon.REF.nikoskelainen.1994.115">Nikoskelainen 1994</xref>]; this finding has not been replicated in other populations [<xref ref-type="bibr" rid="lhon.REF.bower.1992.1427">Bower et al 1992</xref>].</p>
        </sec>
        <sec id="lhon.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Some broad categorization can be made with regard to specific LHON-causing pathogenic variants:</p>
          <list list-type="bullet">
            <list-item>
              <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material> is associated with the worst impairment in visual function.</p>
            </list-item>
            <list-item>
              <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material> has an intermediate phenotype.</p>
            </list-item>
            <list-item>
              <p><inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material> is associated with the best long-term visual outcome.</p>
            </list-item>
          </list>
          <p>It must be emphasized that recovery of visual function in LHON, if it does occur, is usually incomplete. Reported visual recovery rates among persons with LHON are summarized in <xref ref-type="table" rid="lhon.T.visual_recovery_rates_by_pathogen">Table 3</xref>; the lifetime risk for visual failure in individuals with a homoplasmic primary LHON-causing pathogenic variant by sex and age is summarized in <xref ref-type="table" rid="lhon.T.lifetime_risk_for_visual_failure">Table 4</xref>.</p>
          <table-wrap id="lhon.T.visual_recovery_rates_by_pathogen" orientation="portrait" position="anchor">
            <label>Table 3. </label>
            <caption>
              <p>Visual Recovery Rates by Pathogenic Variant in Individuals with LHON</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mitochondrial DNA Variant</th>
                  <th id="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Visual Recovery&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">References</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material>
                  </td>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4%-25%</td>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="lhon.REF.newman.1991.750">Newman et al [1991]</xref>, <xref ref-type="bibr" rid="lhon.REF.harding.1995.77">Harding et al [1995]</xref>, <xref ref-type="bibr" rid="lhon.REF.lam.2014.428">Lam et al [2014]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material>
                  </td>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">37%-64%</td>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="lhon.REF.johns.1993.495">Johns et al [1993]</xref>, <xref ref-type="bibr" rid="lhon.REF.macmillan.1998.417">Macmillan et al [1998]</xref>, <xref ref-type="bibr" rid="lhon.REF.spruijt.2006.676">Spruijt et al [2006]</xref></td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material>
                  </td>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15%-25%&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_lhon.T.visual_recovery_rates_by_pathogen_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><xref ref-type="bibr" rid="lhon.REF.johns.1992b.1577">Johns et al [1992b]</xref>, <xref ref-type="bibr" rid="lhon.REF.harding.1995.77">Harding et al [1995]</xref>, <xref ref-type="bibr" rid="lhon.REF.spruijt.2006.676">Spruijt et al [2006]</xref></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="lhon.TF.3.1">
                <label>1. </label>
                <p>Different criteria have been used to define visual recovery; the range partly reflects this variability.</p>
              </fn>
              <fn id="lhon.TF.3.2">
                <label>2. </label>
                <p>Although published reports would appear to indicate otherwise, the <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material> pathogenic variant is generally accepted among experts as having the worst visual recovery rate [Author, personal communication].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <table-wrap id="lhon.T.lifetime_risk_for_visual_failure" orientation="portrait" position="anchor">
            <label>Table 4. </label>
            <caption>
              <p>Lifetime Risk for Visual Failure in Individuals with a Homoplasmic Primary LHON-Causing Mitochondrial DNA Pathogenic Variant by Study</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1">Mitochondrial DNA Pathogenic Variant</th>
                  <th id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Risk of Developing Symptoms</th>
                  <th id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3">Median Age at Onset (Males)</th>
                  <th id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4">Male/Female Ratio</th>
                  <th id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5">Reference</th>
                </tr>
                <tr>
                  <th headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2" id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Males</th>
                  <th headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2" id="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Females</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.3460G&#x0003e;A</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">32%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">15%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20 yrs</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">4.3:1</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="lhon.REF.nikoskelainen.1994.115">Nikoskelainen [1994]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.3460G&#x0003e;A</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">49%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">28%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">22 yrs</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">1.7:1</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="lhon.REF.man.2003.333">Man et al [2003]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.11778G&#x0003e;A</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">43%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">11%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">24 yrs</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">3.7:1</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="lhon.REF.harding.1995.77">Harding et al [1995]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.11778G&#x0003e;A</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">51%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">9%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">22 yrs</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">5.1:1</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="lhon.REF.man.2003.333">Man et al [2003]</xref>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.14484T&#x0003e;C</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">47%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_2 hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">8%</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">20 yrs</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">7.7:1</td>
                  <td headers="hd_h_lhon.T.lifetime_risk_for_visual_failure_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">
                    <xref ref-type="bibr" rid="lhon.REF.macmillan.1998.417">Macmillan et al [1998]</xref>
                  </td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p>A multiple sclerosis-like illness has been reported in association with all three primary mtDNA LHON-causing pathogenic variants (<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material>, <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material>, and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material>), but with a female bias [<xref ref-type="bibr" rid="lhon.REF.pfeffer.2013.2073">Pfeffer et al 2013</xref>].</p>
        </sec>
        <sec id="lhon.Penetrance">
          <title>Penetrance</title>
          <p>LHON-causing mtDNA pathogenic variants are characterized by reduced penetrance. An individual can only develop LHON if a pathogenic mtDNA LHON-causing variant is present, but approximately 50% of males and 90% of females who harbor a primary LHON-causing mtDNA pathogenic variant do not develop blindness. It must be stressed that penetrance can vary markedly in different branches of the same family and between families harboring the same LHON-causing mtDNA pathogenic variants, which complicates genetic counseling at the individual level. Additional environmental and genetic factors interact with the primary mtDNA pathogenic variant and determine whether an individual ultimately develops optic nerve dysfunction and visual failure. The two most important risk factors for visual loss are sex and age (see <xref ref-type="table" rid="lhon.T.lifetime_risk_for_visual_failure">Table 4</xref>) [<xref ref-type="bibr" rid="lhon.REF.yuwaiman.2009.145">Yu-Wai-Man et al 2009</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Age-related penetrance of LHON.</bold> The penetrance of LHON is age specific. The 95<sup>th</sup> centile for age at onset is 50 years for all three primary pathogenic variants. Thus, a clinically unaffected male age 50 years has less than a 1/20 chance of losing his vision [<xref ref-type="bibr" rid="lhon.REF.man.2003.333">Man et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Heteroplasmy.</bold> Many mitochondria (and thus many mtDNA molecules) are present in each cell. Some individuals with a pathogenic LHON-causing mtDNA variant have a mixture of mutated and wild-type species of mtDNA, a finding referred to as heteroplasmy. Heteroplasmy is present in 10%-15% of individuals with a LHON-causing mtDNA variant. In one study, individuals with a m.11778G&#x0003e;A pathogenic variant load of less than 75% in their leukocytes were unaffected [<xref ref-type="bibr" rid="lhon.REF.smith.1993.1486">Smith et al 1993</xref>]. In a retrospective analysis of 17 families heteroplasmic for the m.11778G&#x0003e;A pathogenic variant, males with a mutational load greater than 60% in their leukocytes had an increased frequency of optic neuropathy than did those with lower mutational loads [<xref ref-type="bibr" rid="lhon.REF.chinnery.2001.235">Chinnery et al 2001</xref>]. However, quantifying the level of heteroplasmy for the purpose of presymptomatic testing is limited as the majority of individuals with a LHON-causing mtDNA variant are homoplasmic.</p>
            </list-item>
          </list>
        </sec>
        <sec id="lhon.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been seen in LHON.</p>
        </sec>
        <sec id="lhon.Nomenclature">
          <title>Nomenclature</title>
          <p>In the past, LHON was sometimes referred to as Leber hereditary optic neuroretinopathy; this term is outdated and should not be used.</p>
        </sec>
        <sec id="lhon.Prevalence">
          <title>Prevalence</title>
          <p>In the North East of England, 1:8,500 individuals were found to harbor a pathogenic LHON-causing variant; 1:31,000 had experienced visual loss as a result of LHON [<xref ref-type="bibr" rid="lhon.REF.man.2003.333">Man et al 2003</xref>, <xref ref-type="bibr" rid="lhon.REF.gorman.2015.753">Gorman et al 2015</xref>]. Fairly similar figures have been reported in other northern European populations, with a disease prevalence of 1:39,000 in the Netherlands and 1:50,000 in Finland [<xref ref-type="bibr" rid="lhon.REF.spruijt.2006.676">Spruijt et al 2006</xref>, <xref ref-type="bibr" rid="lhon.REF.puomila.2007.1079">Puomila et al 2007</xref>].</p>
        </sec>
      </sec>
      <sec id="lhon.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Mitochondrial DNA pathogenic variants are responsible for a heterogeneous group of inherited diseases (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>) that often cause a progressive neurologic disorder in association with multi-organ involvement (e.g., diabetes mellitus, cardiomyopathy) [<xref ref-type="bibr" rid="lhon.REF.mcfarland.2010.829">McFarland et al 2010</xref>, <xref ref-type="bibr" rid="lhon.REF.lightowlers.2015.1494">Lightowlers et al 2015</xref>].</p>
        <list list-type="bullet">
          <list-item>
            <p>In a few families, mtDNA complex I pathogenic variants cause optic atrophy in association with severe neurologic deficits including ataxia, dystonia, and encephalopathy [<xref ref-type="bibr" rid="lhon.REF.jun.1994.6206">Jun et al 1994</xref>, <xref ref-type="bibr" rid="lhon.REF.de_vries.1996.703">De Vries et al 1996</xref>, <xref ref-type="bibr" rid="lhon.REF.gropman.2004.377">Gropman et al 2004</xref>, <xref ref-type="bibr" rid="lhon.REF.tarnopolsky.2004.372">Tarnopolsky et al 2004</xref>, <xref ref-type="bibr" rid="lhon.REF.watanabe.2006.31">Watanabe et al 2006</xref>].</p>
          </list-item>
          <list-item>
            <p>Two mtDNA complex I single-nucleotide variants, m.3376G&#x0003e;A and m.3697G&#x0003e;A, have also been identified in individuals with a LHON-like optic neuropathy and clinical features of <related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object> (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">e</italic>ncephalomyopathy, <italic toggle="yes">l</italic>actic <italic toggle="yes">a</italic>cidosis, and <italic toggle="yes">s</italic>trokelike episodes) [<xref ref-type="bibr" rid="lhon.REF.blakely.2005.623">Blakely et al 2005</xref>, <xref ref-type="bibr" rid="lhon.REF.spruijt.2007.890">Spruijt et al 2007</xref>].</p>
          </list-item>
        </list>
      </sec>
      <sec id="lhon.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>If the ophthalmologic assessment (including an assessment of visual acuity, color vision, visual fields, and electrophysiology) and molecular genetic testing leave any uncertainty about the diagnosis of Leber hereditary optic neuropathy (LHON), further investigations are appropriate to exclude other potentially reversible causes of bilateral optic neuropathy and to allow for the initiation of prompt treatment before visual loss becomes irreversible. Depending on the clinical presentation and evolution, autoantibody testing and an infectious or vasculitic screen may be warranted. A lumbar puncture should be performed when clinically indicated to evaluate for unmatched oligoclonal bands in suspected cases of demyelination or to exclude infectious and neoplastic causes. The appropriate neuroimaging modality should be requested and the films should ideally be reviewed with an experienced neuroradiologist.</p>
        <p><bold>Acute phase.</bold> A wide range of non-genetic causes of bilateral visual failure must be excluded during the acute phase.</p>
        <p><bold>Atrophic phase.</bold> If an individual is only seen at this stage, it can be difficult to exclude other possible causes of optic atrophy, especially if there is no clear maternal family history. In these cases, neuroimaging of the anterior visual pathways is mandatory while awaiting the results of molecular genetic testing.</p>
      </sec>
      <sec id="lhon.Management">
        <title>Management</title>
        <sec id="lhon.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with Leber hereditary optic neuropathy (LHON), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of best corrected visual acuity</p>
            </list-item>
            <list-item>
              <p>Assessment of visual fields with static or kinetic perimetry</p>
            </list-item>
            <list-item>
              <p>ECG. Although a relatively rare finding, an ECG may reveal a pre-excitation syndrome in both symptomatic and asymptomatic individuals who have a LHON-causing mtDNA variant. Even when present, such an ECG finding does not necessitate further intervention in the absence of cardiac symptoms.</p>
            </list-item>
            <list-item>
              <p>Screening for possible associated neurologic complications, which can further compound the visual impairment among individuals with LHON</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="lhon.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management of affected individuals is supportive and includes provision of visual aids, occupational rehabilitation, and registration with the relevant local social services.</p>
          <p>A minority of individuals with LHON develop neurologic features including ataxia, peripheral neuropathy, nonspecific myopathy, and movement disorders. This group of affected individuals should be managed by a multidisciplinary team of physicians and allied professionals to minimize the functional consequences of these neurologic complications.</p>
          <p>In those individuals who are found to have pre-excitation syndrome on ECG, referral to a cardiologist can be considered; treatment for symptomatic individuals with pre-excitation syndrome is the same as in the general population.</p>
        </sec>
        <sec id="lhon.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>There is evidence that raised intraocular pressure could be a risk factor triggering visual loss in individuals at risk for developing LHON. Until further evidence becomes available, it is reasonable to set a lower threshold for initiating treatment for raised intraocular pressure in individuals with a LHON-causing variant given the possible deleterious consequences of raised intraocular pressure on mitochondrial function and retinal ganglion cell survival [<xref ref-type="bibr" rid="lhon.REF.thouin.2013.e63446">Thouin et al 2013</xref>].</p>
        </sec>
        <sec id="lhon.Surveillance">
          <title>Surveillance</title>
          <p>Ongoing surveillance of asymptomatic individuals harboring LHON-causing mtDNA variants is not necessary; however, they should be advised to seek immediate medical attention should they experience any visual disturbance.</p>
          <p>The frequency of follow-up for affected individuals varies depending on the individual&#x02019;s personal circumstances and the availability of healthcare locally.</p>
        </sec>
        <sec id="lhon.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals harboring established LHON-causing mtDNA variants should be strongly advised not to smoke and to moderate their alcohol intake, avoiding binge-drinking episodes. Although based largely on anecdotal evidence, avoidance of other environmental factors that have been implicated in precipitating visual loss in LHON (e.g., head trauma, industrial toxins, drugs with mitochondrial toxic effects) would seem reasonable.</p>
        </sec>
        <sec id="lhon.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="lhon.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="lhon.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><bold>Idebenone.</bold> Small case series have reported that oral administration of idebenone (a short-chain synthetic benzoquinone; 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone) and/or vitamin supplementation (B<sub>12</sub> and C) can accelerate visual recovery and improve final visual outcome in patients with LHON [<xref ref-type="bibr" rid="lhon.REF.mashima.2000.166">Mashima et al 2000</xref>, <xref ref-type="bibr" rid="lhon.REF.carelli.2001.813">Carelli et al 2001</xref>]. A subsequent report of two individuals with LHON showed no visual benefit from idebenone and multivitamin supplementation [<xref ref-type="bibr" rid="lhon.REF.barnils.2007.377">Barnils et al 2007</xref>].</p>
          <p>To address these conflicting anecdotal findings, a Phase II double-blind randomized placebo-controlled trial was conducted to investigate the efficacy, safety, and tolerability of oral idebenone in LHON: RHODOS (Rescue of Hereditary Optic Disease Outpatient Study). In total, 85 affected individuals harboring one of the three primary mtDNA LHON-causing variants (<inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.3460G&#x0003e;A</inline-supplementary-material>, <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.11778G&#x0003e;A</inline-supplementary-material>, and <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">m.14484T&#x0003e;C</inline-supplementary-material>) were successfully enrolled in this multicenter study [<xref ref-type="bibr" rid="lhon.REF.klopstock.2013.e230">Klopstock et al 2013</xref>]. Research subjects were assigned in a two-to-one randomization ratio to receive either idebenone (at a dose of 300 mg/3x/day) or placebo. This dose of idebenone was found to be safe with no significant drug-related adverse events. Affected individuals with discordant visual acuities (defined as a difference of &#x0003e;0.2 LogMAR between the two eyes) and at highest risk for further visual loss in the least affected eye were more likely to benefit from treatment with idebenone [<xref ref-type="bibr" rid="lhon.REF.klopstock.2011.2677">Klopstock et al 2011</xref>].</p>
          <p>In the follow-up study (RHODOS-OFU), the beneficial effect of six months of treatment with idebenone appeared to persist despite discontinuation of the active medication at the end of the trial [<xref ref-type="bibr" rid="lhon.REF.klopstock.2013.e230">Klopstock et al 2013</xref>]. In a large retrospective study involving 103 individuals with LHON, 44 with visual loss of one year&#x02019;s duration or less were treated with idebenone and followed up for at least five years. A greater proportion of those in the treated group recovered vision compared with the untreated group, and the most consistent factor associated with visual recovery was an early initiation of treatment during the acute phase of the disease process [<xref ref-type="bibr" rid="lhon.REF.carelli.2011.e188">Carelli et al 2011</xref>]. It must be stressed that idebenone will not completely reverse the significant damage already sustained to the optic nerve, but in those affected individuals who do respond, there is an increased rate and likelihood of visual recovery compared with the known natural history.</p>
          <p>There is no evidence to support the prophylactic use of idebenone among asymptomatic individuals with LHON-causing mtDNA variants.</p>
          <p><bold>EPI-743.</bold> In an open-label study of five individuals with acute LHON treated within 90 days of disease conversion, the antioxidant &#x003b1;-tocotrienol-quinone (EPI-743), a vitamin E derivative, has shown early promise [<xref ref-type="bibr" rid="lhon.REF.sadun.2012.331">Sadun et al 2012</xref>]. An adequately powered, double-blind, randomized placebo-controlled trial is needed to confirm the visual benefit of this agent in both acute and chronic LHON [<xref ref-type="bibr" rid="lhon.REF.sadun.2012.331">Sadun et al 2012</xref>].</p>
          <p><bold>Gene therapy.</bold> Targeted gene therapy for LHON is being actively explored for affected individuals harboring the m.11778G&#x0003e;A pathogenic variant [<xref ref-type="bibr" rid="lhon.REF.qi.2003.198">Qi et al 2003</xref>, <xref ref-type="bibr" rid="lhon.REF.qi.2004.182">Qi et al 2004</xref>, <xref ref-type="bibr" rid="lhon.REF.qi.2007.268">Qi et al 2007</xref>, <xref ref-type="bibr" rid="lhon.REF.ellouze.2008.373">Ellouze et al 2008</xref>, <xref ref-type="bibr" rid="lhon.REF.lam.2010.1129">Lam et al 2010</xref>]. Promising pre-clinical data based on in vitro and rodent models have resulted in the recent launch of pivotal clinical trials for affected individuals with the m.11778G&#x0003e;A pathogenic variant involving the intravitreal injection of a modified adeno-associated virus (AAV2) vector carrying the replacement <italic toggle="yes">MTND4</italic> subunit (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=LHON+AAV2+&#x00026;recr=&#x00026;rslt=&#x00026;type=&#x00026;cond=&#x00026;intr=&#x00026;titles=&#x00026;outc=&#x00026;spons=&#x00026;lead=&#x00026;id=&#x00026;state1=&#x00026;cntry1=&#x00026;state2=&#x00026;cntry2=&#x00026;state3=&#x00026;cntry3=&#x00026;locn=&#x00026;gndr=&#x00026;rcv_s=&#x00026;rcv_e=&#x00026;lup_s=&#x00026;lup_e=">ClinicalTrials.gov</ext-link>).</p>
          <p><bold>Hormone therapy.</bold> The marked male bias in LHON could reflect a protective influence of female sex hormones, and this hypothesis was recently investigated using LHON cybrid cell lines. Treatment with estrogens was found to reduce reactive oxygen species levels in these LHON cybrids, with increased activity of the antioxidant enzyme superoxide dismutase. These beneficial estrogenic effects translated into more efficient mitochondrial oxidative phosphorylation [<xref ref-type="bibr" rid="lhon.REF.giordano.2011.220">Giordano et al 2011</xref>]. Further research is needed to determine whether females with a LHON-causing variant are at increased risk for visual loss in the perimenopausal period and following the onset of menopause.</p>
          <p><bold>Mitochondrial replacement.</bold> In vitro fertilization (IVF) techniques aimed at preventing the maternal transmission of mtDNA pathogenic variants from mother to child are being developed. Pronuclear transfer and metaphase II spindle transfer are the two approaches that are being investigated, and further experimental work to validate the safety and potential clinical applicability of these IVF strategies is currently ongoing [<xref ref-type="bibr" rid="lhon.REF.tachibana.2009.367">Tachibana et al 2009</xref>, <xref ref-type="bibr" rid="lhon.REF.craven.2010.82">Craven et al 2010</xref>, <xref ref-type="bibr" rid="lhon.REF.chinnery.2014.e1004315">Chinnery et al 2014</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="lhon.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="lhon.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Leber hereditary optic neuropathy (LHON) is caused by pathogenic variants in mtDNA and it is strictly transmitted by mitochondrial (maternal) inheritance.</p>
        </sec>
        <sec id="lhon.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a proband is not at risk of having the mtDNA pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The mother of a proband usually has the mtDNA pathogenic variant and may or may not have developed visual loss.</p>
            </list-item>
            <list-item>
              <p>In approximately 60% of cases, a family history of visual loss affecting maternal relatives is present.</p>
            </list-item>
            <list-item>
              <p>Up to 40% of individuals with LHON have no known family history of LHON. The explanation for apparently simplex cases may be absence of a comprehensive and/or reliable family history or, in rare cases, a <italic toggle="yes">de novo</italic> mtDNA pathogenic variant in the proband.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to sibs depends on the genetic status of the mother: if the mother has the mtDNA pathogenic variant, all sibs of a proband will inherit the variant and may or may not have symptoms (see <bold>Offspring of a proband</bold>).</p>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A male (affected or unaffected) with a primary LHON-causing mtDNA variant <bold>cannot</bold> transmit the variant to any of his offspring.</p>
            </list-item>
            <list-item>
              <p>A female (affected or unaffected) with a primary LHON-causing mtDNA variant will transmit the variant to all of her offspring.</p>
            </list-item>
            <list-item>
              <p>The presence of the mtDNA pathogenic variant does not predict the occurrence, age of onset, severity, or rate of progression of visual loss. See <xref ref-type="sec" rid="lhon.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> and <xref ref-type="sec" rid="lhon.Penetrance">Penetrance</xref> for information regarding the risk to individuals with a primary LHON-causing mtDNA variant of being affected.</p>
            </list-item>
            <list-item>
              <p>If an affected female is heteroplasmic for the mtDNA LHON-causing variant, she may transmit a lower level of mutated mtDNA to her offspring, conferring a low disease risk [<xref ref-type="bibr" rid="lhon.REF.chinnery.2001.235">Chinnery et al 2001</xref>].</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The risk to other family members depends on the genetic status of the proband's mother: if the proband's mother has a mtDNA pathogenic variant, her sibs and mother are also at risk.</p>
        </sec>
        <sec id="lhon.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Penetrance.</bold> Genetic counseling for LHON is complicated by the gender- and age-dependent penetrance of the primary LHON-causing mtDNA variants. Large studies have established accurate risks for the m.11778G&#x0003e;A and m.14484T&#x0003e;C pathogenic variants (reviewed in <xref ref-type="bibr" rid="lhon.REF.yuwaiman.2009.145">Yu-Wai-Man et al [2009]</xref>). Confirming the genetic status of an individual at risk for one of these pathogenic variants who is seeking counseling allows for an accurate estimation of the risks, based on established age- and gender-specific penetrance data (see <xref ref-type="sec" rid="lhon.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>). Data for the m.3460G&#x0003e;A pathogenic variant are more limited. Similarly, counseling for the other pathogenic variants requires cautious extrapolation.</p>
          <p><bold>Testing of at-risk asymptomatic adult relatives</bold> of individuals with LHON is possible after molecular genetic testing has identified the specific pathogenic mtDNA variant in the family. Such testing should be performed in the context of formal genetic counseling. The presence of the pathogenic variant in leukocytes confers a lifetime risk, however, such testing is not useful in predicting age of onset, severity, or the rate of progression of visual loss in asymptomatic individuals. The most important factors determining risk are gender and age (see <xref ref-type="sec" rid="lhon.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> and <xref ref-type="sec" rid="lhon.Penetrance">Penetrance</xref>). For example, a male age 18 years has a lifetime risk of approximately 50% for LHON <bold>after</bold> a positive test result. The risk declines with age but, because loss of sight can occur at any age, the risk never falls to zero. In large, multi-generational LHON pedigrees, these risks were known <bold>before</bold> the advent of molecular genetic testing. In smaller families, it is important to confirm the genetic status because it is possible that a pathogenic variant is heteroplasmic in the affected individual or his mother, and it may not be present in every family member. It must be stressed that the penetrance can vary markedly in different branches of the same family and between families harboring the same LHON-causing mtDNA pathogenic variants.</p>
          <p><bold>Testing of asymptomatic individuals younger than age 18 years</bold> who are at risk for adult-onset disorders for which no treatment exists is not considered appropriate, primarily because it negates the autonomy of the child with no compelling benefit. Further, concern exists regarding the potential unhealthy adverse effects that such information may have on family dynamics, the risk of discrimination and stigmatization in the future, and the anxiety that such information may cause.</p>
          <p>It is appropriate to consider testing symptomatic individuals regardless of age in a family with an established diagnosis of LHON.</p>
          <p>For more information, see the National Society of Genetic Counselors <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">position statement</ext-link> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">policy statement</ext-link>: ethical and policy issues in genetic testing and screening of children.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="lhon.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once a mtDNA LHON-causing variant in the mother has been identified, prenatal testing and preimplantation genetic diagnosis [<xref ref-type="bibr" rid="lhon.REF.sallevelt.2013.125">Sallevelt et al 2013</xref>] for a pregnancy at increased risk for LHON are possible options.</p>
          <p>Accurate interpretation of a positive prenatal test result is difficult for the following reasons:</p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of mothers will be homoplasmic for the mtDNA LHON-causing variant. For mothers who are heteroplasmic, the mtDNA mutational load in amniocytes and chorionic villi may not correspond to that of other fetal or adult tissues due to mitotic segregation.</p>
            </list-item>
            <list-item>
              <p>The presence of the mtDNA LHON-causing variant does not predict the occurrence, age of onset, severity, or the rate of progression of visual loss in this mitochondrial genetic disorder. See <xref ref-type="sec" rid="lhon.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> for information regarding the risk to individuals with a primary LHON-causing mtDNA variant of being affected.</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="lhon.Resources">
        <title>Resources</title>
      </sec>
      <sec id="lhon.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="lhon.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
          <p>The ocular pathology in Leber hereditary optic neuropathy (LHON) is limited to the retinal ganglion cell layer with sparing of the retinal pigment epithelium and photoreceptor layers. There is marked cell body and axonal degeneration, with associated demyelination, that extends to the lateral geniculate bodies. A number of pathologic factors have been implicated, including a reduction in the amount of ATP being produced by the mitochondrial respiratory chain (<xref ref-type="table" rid="lhon.T.respiratory_chain_dysfunction_in">Table 1</xref>), impaired glutamate transport, and increased levels of reactive oxygen species production, all of which ultimately trigger retinal ganglion cell death via an apoptotic mechanism [<xref ref-type="bibr" rid="lhon.REF.danielson.2002.5810">Danielson et al 2002</xref>, <xref ref-type="bibr" rid="lhon.REF.beretta.2004.2183">Beretta et al 2004</xref>, <xref ref-type="bibr" rid="lhon.REF.zanna.2005.997">Zanna et al 2005</xref>, <xref ref-type="bibr" rid="lhon.REF.levin.2015.152">Levin 2015</xref>].</p>
          <p>Although LHON has a well-defined clinical and molecular genetic phenotype, the pathophysiology is complex and the selective vulnerability of retinal ganglion cells in this mitochondrial disorder remains unexplained [<xref ref-type="bibr" rid="lhon.REF.yuwaiman.2011.81">Yu-Wai-Man et al 2011</xref>]. It is also not known why otherwise entirely healthy individuals suddenly develop optic nerve dysfunction in young adulthood. The incomplete penetrance and predilection for males to lose vision also imply that additional genetic and/or environmental factors must modulate the phenotypic expression of LHON (see <xref ref-type="sec" rid="lhon.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref> and <xref ref-type="sec" rid="lhon.Penetrance">Penetrance</xref>). Alternatively, the gender bias could also result from a combination of subtle anatomic, hormonal, and/or physiologic variations between males and females.</p>
          <p><bold>Benign variants.</bold> See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
          <p><bold>Pathogenic variants.</bold> See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
          <p>Many different mtDNA variants have been associated with LHON in the literature and in numerous online databases (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/foswiki/bin/view/MITOMAP/MutationsLHON">www.mitomap.org</ext-link>). Some of these changes are rare polymorphisms and some are common sequence variants in the normal population. Great caution should therefore be exercised in attributing significance to a "rare" LHON-causing mtDNA variant found in a single affected individual or family.</p>
          <p>See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table5.pdf" content-type="local-data">Table 5</inline-supplementary-material> (pdf) for a list of mtDNA variants for which strong evidence of pathogenicity exists.</p>
          <p>See <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="lhon-Table6.pdf" content-type="local-data">Table 6</inline-supplementary-material> (pdf) for a list of putative pathogenic variants.</p>
          <p><bold>Normal gene product.</bold> See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
          <p><bold>Abnormal gene product.</bold> See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>.</p>
        </sec>
      </sec>
      <sec id="lhon.References">
        <title>References</title>
        <sec id="lhon.Published_GuidelinesConsensus_State">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="lhon.Published_GuidelinesConsensus_State.reflist0">
            <ref id="lhon.REF1">
              <mixed-citation publication-type="web">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf">online</ext-link>. 2013. Accessed 3-2-17.</mixed-citation>
            </ref>
            <ref id="lhon.REF2">
              <mixed-citation publication-type="web">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 3-2-17.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="lhon.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="lhon.Literature_Cited.reflist0">
            <ref id="lhon.REF.achilli.2012.e42242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Achilli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iommarini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olivieri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pala</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hooshiar Kashani</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Morgia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pizza</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Negri</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moulignier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducos</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orssaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leo-Kottler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fauser</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissinger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torroni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Rare primary mitochondrial DNA mutations and probable synergistic variants in Leber's hereditary optic neuropathy.</article-title>
                <source>PLoS One.</source>
                <year>2012</year>
                <volume>7</volume>
                <fpage>e42242</fpage>
                <pub-id pub-id-type="pmid">22879922</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.barboni.2006.5303">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Morgia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellusci</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Negri</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbonelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Leber's hereditary optic neuropathy with childhood onset.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2006</year>
                <volume>47</volume>
                <fpage>5303</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17122117</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.barnils.2007.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barnils</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesa</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munoz</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer-Artola</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arruga</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <comment>[Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy]</comment>
                <source>Arch Soc Esp Oftalmol</source>
                <volume>82</volume>
                <fpage>377</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">17573650</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.beretta.2004.2183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beretta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mattavelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sala</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tremolizzo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinuzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrarese</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines.</article-title>
                <source>Brain</source>
                <volume>127</volume>
                <fpage>2183</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">15342361</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.bhatti.1999.28">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bhatti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation.</article-title>
                <source>J Neuroophthalmol</source>
                <volume>19</volume>
                <fpage>28</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">10098545</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.blakely.2005.623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Silva</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarzer</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harrower</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dawidek</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>LHON/MELAS overlap syndrome associated with a mitochondrial MTND1 gene mutation.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>13</volume>
                <fpage>623</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15657614</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.bower.1992.1427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bower</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hawley</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Cardiac arrhythmia and Leber's hereditary optic neuropathy.</article-title>
                <source>Lancet.</source>
                <year>1992</year>
                <volume>339</volume>
                <fpage>1427</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1350847</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.carelli.2011.e188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Morgia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbonelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Negri</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerriero</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aggarwal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avoni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Idebenone treatment in Leber's hereditary optic neuropathy.</article-title>
                <source>Brain.</source>
                <year>2011</year>
                <volume>134</volume>
                <fpage>e188</fpage>
                <pub-id pub-id-type="pmid">21810891</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.carelli.2001.813">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meletti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vetrugno</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Provini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancardi</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bandini</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases.</article-title>
                <source>J Neurol Neurosurg Psychiatry</source>
                <volume>71</volume>
                <fpage>813</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11723211</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.chinnery.2001.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>NN</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Leber hereditary optic neuropathy: Does heteroplasmy influence the inheritance and expression of the G11778A mitochondrial DNA mutation?</article-title>
                <source>Am J Med Genet</source>
                <volume>98</volume>
                <fpage>235</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">11169561</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.chinnery.2014.e1004315">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craven</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitalipov</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>The challenges of mitochondrial replacement.</article-title>
                <source>PloS Genet</source>
                <year>2014</year>
                <volume>10</volume>
                <fpage>e1004315</fpage>
                <pub-id pub-id-type="pmid">24762741</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.craven.2010.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Craven</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuppen</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greggains</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbottle</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cree</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murdoch</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.</article-title>
                <source>Nature</source>
                <volume>465</volume>
                <fpage>82</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20393463</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.danielson.2002.5810">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Danielson</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinuzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schapira</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortopassi</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Cells bearing mutations causing Leber's hereditary optic neuropathy are sensitized to Fas-Induced apoptosis.</article-title>
                <source>J Biol Chem</source>
                <volume>277</volume>
                <fpage>5810</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11741983</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.de_vries.1996.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Vries</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Went</surname>
                    <given-names>LN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruyn</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholte</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofstra</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolhuis</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Oost</surname>
                    <given-names>BA</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Genetic and biochemical impairment of mitochondrial complex I activity in a family with Leber hereditary optic neuropathy and hereditary spastic dystonia.</article-title>
                <source>Am J Hum Genet</source>
                <volume>58</volume>
                <fpage>703</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">8644732</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.dimitriadis.2014.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dimitriadis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonhardt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkman</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korsten</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Leber's hereditary optic neuropathy with late disease onset: clinical and molecular characteristics of 20 patients.</article-title>
                <source>Orphanet J Rare Dis.</source>
                <year>2014</year>
                <volume>9</volume>
                <fpage>158</fpage>
                <pub-id pub-id-type="pmid">25338955</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.ellouze.2008.373">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ellouze</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Augustin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouaita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simonutti</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forster</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picaud</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sahel</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corral-Debrinski</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2008</year>
                <volume>83</volume>
                <fpage>373</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">18771762</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.giordano.2011.220">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montopoli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orlandi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fantin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross-Cisneros</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caparrotta</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinuzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragazzi</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>d'Amati</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy.</article-title>
                <source>Brain.</source>
                <volume>134</volume>
                <fpage>220</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">20943885</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.gorman.2015.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alston</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feeney</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease.</article-title>
                <source>Ann Neurol.</source>
                <year>2015</year>
                <volume>77</volume>
                <fpage>753</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">25652200</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.gropman.2004.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gropman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perng</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krasnewich</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chernoff</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tifft</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation.</article-title>
                <source>Am J Med Genet A</source>
                <volume>124A</volume>
                <fpage>377</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">14735585</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.harding.1995.77">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sweeney</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Govan</surname>
                    <given-names>GG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Riordan-Eva</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Pedigree analysis in Leber hereditary optic neuropathy families with a pathogenic mtDNA mutation.</article-title>
                <source>Am J Hum Genet</source>
                <volume>57</volume>
                <fpage>77</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">7611298</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.horv_th.2000.65">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horv&#x000e1;th</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karcagi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>R&#x000f3;zsa</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Komoly</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochm&#x000fc;ller</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Leber's hereditary optic neuropathy presenting as multiple sclerosis- like disease of the CNS.</article-title>
                <source>J Neurol</source>
                <volume>247</volume>
                <fpage>65</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">10701903</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.howell.1992.443">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCullough</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodis-Wollner</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Molecular genetic analysis of a sporadic case of Leber hereditary optic neuropathy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>50</volume>
                <fpage>443</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1734726</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.jia.2006.851">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jia</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Molecular epidemiology of mtDNA mutations in 903 Chinese families suspected with Leber hereditary optic neuropathy.</article-title>
                <source>J Hum Genet</source>
                <volume>51</volume>
                <fpage>851</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16972023</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.johns.1993.495">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heher</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>NR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KH</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Leber's hereditary optic neuropathy. Clinical manifestations of the 14484 mutation.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>111</volume>
                <fpage>495</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8470982</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.johns.1992a.1551">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neufeld</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <year>1992a</year>
                <article-title>An ND-6 mitochondrial DNA mutation associated with Leber hereditary optic neuropathy.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>187</volume>
                <fpage>1551</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1417830</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.johns.1992b.1577">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>NR</given-names>
                  </name>
                </person-group>
                <year>1992b</year>
                <article-title>Leber's hereditary optic neuropathy. Clinical manifestations of the 3460 mutation.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>110</volume>
                <fpage>1577</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">1444915</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.jun.1994.6206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jun</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1994</year>
                <article-title>A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia.</article-title>
                <source>Proc Natl Acad Sci U S A</source>
                <volume>91</volume>
                <fpage>6206</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8016139</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.kirkman.2009.3112">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kirkman</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korsten</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leonhardt</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimitriadis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Quality of life in patients with leber hereditary optic neuropathy.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <volume>50</volume>
                <fpage>3112</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19255150</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.klopstock.2013.e230">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000fc;chner</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallenm&#x000fc;ller</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nwali</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Livonius</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reznicek</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coppard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.</article-title>
                <source>Brain.</source>
                <volume>136</volume>
                <fpage>e230</fpage>
                <pub-id pub-id-type="pmid">23388409</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.klopstock.2011.2677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klopstock</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dimitriadis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heck</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bailie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atawan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chattopadhyay</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schubert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rummey</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metz</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leinonen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meier</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>A randomized placebo-controlled trial of idebenone in Leber&#x02019;s hereditary optic neuropathy.</article-title>
                <source>Brain.</source>
                <year>2011</year>
                <volume>134</volume>
                <fpage>2677</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">21788663</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.lam.2010.1129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feuer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abukhalil</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porciatti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauswirth</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Leber hereditary optic neuropathy gene therapy clinical trial recruitment: year 1.</article-title>
                <source>Arch Ophthalmol.</source>
                <volume>128</volume>
                <fpage>1129</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">20837795</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.lam.2014.428">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feuer</surname>
                    <given-names>WJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schiffman</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porciatti</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenbroucke</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosa</surname>
                    <given-names>PR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregori</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.</article-title>
                <source>JAMA Ophthalmol.</source>
                <year>2014</year>
                <volume>132</volume>
                <fpage>428</fpage>
                <lpage>36</lpage>
                <pub-id pub-id-type="pmid">24525545</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.levin.2015.152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levin</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Superoxide generation explains common features of optic neuropathies associated with cecocentral scotomas.</article-title>
                <source>J Neuroophthalmol</source>
                <volume>35</volume>
                <fpage>152</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">25985432</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.lightowlers.2015.1494">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Mutations causing mitochondrial disease: What is new and what challenges remain?</article-title>
                <source>Science.</source>
                <year>2015</year>
                <volume>349</volume>
                <fpage>1494</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">26404827</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.mackey.1996.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikoskelainen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bronte-Stewart</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harding</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Govan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bolhuis</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Norby</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Primary pathogenic mtDNA mutations in multigeneration pedigrees with Leber hereditary optic neuropathy.</article-title>
                <source>Am J Hum Genet</source>
                <volume>59</volume>
                <fpage>481</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8755941</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.macmillan.1998.417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Macmillan</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkham</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fu</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allison</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andermann</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortier</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hare</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quercia</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zackon</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoubridge</surname>
                    <given-names>EA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Pedigree analysis of French Canadian families with T14484C Leber's hereditary optic neuropathy.</article-title>
                <source>Neurology</source>
                <volume>50</volume>
                <fpage>417</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">9484365</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.man.2003.333">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Man</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The epidemiology of Leber hereditary optic neuropathy in the North East of England.</article-title>
                <source>Am J Hum Genet</source>
                <volume>72</volume>
                <fpage>333</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12518276</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.man.2002.162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Man</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Leber hereditary optic neuropathy.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>162</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">11897814</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.martikainen.2016.668">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martikainen</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alston</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burn</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease.</article-title>
                <source>JAMA Neurol.</source>
                <year>2016</year>
                <volume>73</volume>
                <fpage>668</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">27111573</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.mashima.2000.166">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mashima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kigasawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakakura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?</article-title>
                <source>J Neuroophthalmol</source>
                <volume>20</volume>
                <fpage>166</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">11001192</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.mashima.1998.403">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mashima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wakakura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kigasawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudoh</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Spectrum of pathogenic mitochondrial DNA mutations and clinical features in Japanese families with Leber's hereditary optic neuropathy.</article-title>
                <source>Curr Eye Res</source>
                <volume>17</volume>
                <fpage>403</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">9561832</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.matthews.2015.537">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matthews</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enzinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fazekas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rovira</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciccarelli</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dotti</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filippi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frederiksen</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giorgio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>K&#x000fc;ker</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lukas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocca</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Stefano</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toosy</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yousry</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>MAGNIMS Network. (2015) MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2015</year>
                <volume>86</volume>
                <fpage>537</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">25053773</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.mcfarland.2007.911">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morris</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foster</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuppen</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesh</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorman</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <article-title>Homoplasmy, heteroplasmy, and mitochondrial dystonia.</article-title>
                <source>Neurology.</source>
                <year>2007</year>
                <volume>69</volume>
                <fpage>911</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17724295</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.mcfarland.2010.829">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>A neurological perspective on mitochondrial disease.</article-title>
                <source>Lancet Neurol.</source>
                <volume>9</volume>
                <fpage>829</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20650404</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.newman.1991.750">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lott</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>The clinical characteristics of pedigrees of Leber's hereditary optic neuropathy with the 11778 mutation.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>111</volume>
                <fpage>750</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">2039048</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.nikoskelainen.1994.115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nikoskelainen</surname>
                    <given-names>EK</given-names>
                  </name>
                </person-group>
                <article-title>Clinical picture of LHON.</article-title>
                <source>Clin Neurosci</source>
                <year>1994</year>
                <volume>2</volume>
                <fpage>115</fpage>
                <lpage>20</lpage>
              </element-citation>
            </ref>
            <ref id="lhon.REF.palace.2009.24">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Palace</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.</article-title>
                <source>J Neurol Sci.</source>
                <volume>286</volume>
                <fpage>24</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19800080</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.pfeffer.2013.2073">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pfeffer</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Compston</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations.</article-title>
                <source>Neurology.</source>
                <year>2013</year>
                <volume>81</volume>
                <fpage>2073</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">24198293</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.puomila.2007.1079">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puomila</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivioja</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savontaus</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koivumaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huoponen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikoskelainen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>15</volume>
                <fpage>1079</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">17406640</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.qi.2003.198">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewin</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauswirth</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Suppression of complex I gene expression induces optic neuropathy.</article-title>
                <source>Ann Neurol</source>
                <volume>53</volume>
                <fpage>198</fpage>
                <lpage>205</lpage>
                <pub-id pub-id-type="pmid">12557286</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.qi.2004.182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewin</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauswirth</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I.</article-title>
                <source>Ann Neurol</source>
                <volume>56</volume>
                <fpage>182</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">15293270</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.qi.2007.268">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Qi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hauswirth</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewin</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guy</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Use of mitochondrial antioxidant defenses for rescue of cells with a Leber hereditary optic neuropathy-causing mutation.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>125</volume>
                <fpage>268</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">17296905</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.ramos.2009.1666">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramos</surname>
                    <given-names>CV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellusci</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carbonelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berezovsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tamaki</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cinoto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacai</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moraes-Filho</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miura</surname>
                    <given-names>HM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iommarini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Negri</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortelli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomao</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Association of optic disc size with development and prognosis of Leber's hereditary optic neuropathy.</article-title>
                <source>Invest Ophthalmol Vis Sci.</source>
                <year>2009</year>
                <volume>50</volume>
                <fpage>1666</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">19098324</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.sadun.2012.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chicani</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross-Cisneros</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thoolen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shrader</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Effect of EPI-743 on the clinical course of the mitochondrial disease Leber hereditary optic neuropathy.</article-title>
                <source>Arch Neurol.</source>
                <year>2012</year>
                <volume>69</volume>
                <fpage>331</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22410442</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.sadun.2006.51">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomao</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berezovsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denegri</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quiros</surname>
                    <given-names>PA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chicani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ventura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sherman</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutter</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belfort</surname>
                    <given-names>R</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Subclinical carriers and conversions in Leber hereditary optic neuropathy: a prospective psychophysical study.</article-title>
                <source>Trans Am Ophthalmol Soc</source>
                <volume>104</volume>
                <fpage>51</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">17471325</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.sallevelt.2013.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sallevelt</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreesen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dr&#x000fc;sedau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spierts</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coonen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Tienen</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Golde</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraedts</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Die-Smulders</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>HJ</given-names>
                  </name>
                </person-group>
                <article-title>Preimplantation genetic diagnosis in mitochondrial DNA disorders: challenge and success.</article-title>
                <source>J Med Genet.</source>
                <year>2013</year>
                <volume>50</volume>
                <fpage>125</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">23339111</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.savini.2005.127">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Savini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cortelli</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Negri</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longanesi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Retinal nerve fiber layer evaluation by optical coherence tomography in unaffected carriers with Leber's hereditary optic neuropathy mutations.</article-title>
                <source>Ophthalmology</source>
                <volume>112</volume>
                <fpage>127</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15629832</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.smith.1993.1486">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johns</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heher</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>NR</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Heteroplasmy in Leber's hereditary optic neuropathy.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>111</volume>
                <fpage>1486</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">8240102</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.spruijt.2006.676">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spruijt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolbach</surname>
                    <given-names>DN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plomp</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bauer</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Die-Smulders</surname>
                    <given-names>CE</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Influence of mutation type on clinical expression of Leber hereditary optic neuropathy.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>141</volume>
                <fpage>676</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16564802</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.spruijt.2007.890">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Spruijt</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeets</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendrickx</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettink-Remeijer</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maat-Kievit</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schoonderwoerd</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sluiter</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>IF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hintzen</surname>
                    <given-names>RQ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A MELAS-associated ND1 mutation causing leber hereditary optic neuropathy and spastic dystonia.</article-title>
                <source>Arch Neurol</source>
                <volume>64</volume>
                <fpage>890</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">17562939</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.tachibana.2009.367">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tachibana</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sparman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sritanaudomchai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clepper</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woodward</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsey</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kolotushkina</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitalipov</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Mitochondrial gene replacement in primate offspring and embryonic stem cells.</article-title>
                <source>Nature</source>
                <volume>461</volume>
                <fpage>367</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">19710649</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.tarnopolsky.2004.372">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myint</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maxner</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robitaille</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>BH</given-names>
                  </name>
                </person-group>
                <article-title>Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2004</year>
                <volume>124A</volume>
                <fpage>372</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">14735584</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.thouin.2013.e63446">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thouin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Raised intraocular pressure as a potential risk factor for visual loss in leber hereditary optic neuropathy.</article-title>
                <source>PLoS One.</source>
                <volume>8</volume>
                <fpage>e63446</fpage>
                <pub-id pub-id-type="pmid">23667621</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.wallace.1988.1427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Singh</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lott</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodge</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schurr</surname>
                    <given-names>TG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lezza</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsas</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikoskelainen</surname>
                    <given-names>EK</given-names>
                  </name>
                </person-group>
                <year>1988</year>
                <article-title>Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.</article-title>
                <source>Science</source>
                <volume>242</volume>
                <fpage>1427</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">3201231</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.watanabe.2006.31">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mita</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takita</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imamura</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Leber's hereditary optic neuropathy with dystonia in a Japanese family.</article-title>
                <source>J Neurol Sci</source>
                <volume>243</volume>
                <fpage>31</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16380132</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.yuwaiman.2011.81">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.</article-title>
                <source>Prog Retin Eye Res.</source>
                <year>2011</year>
                <volume>30</volume>
                <fpage>81</fpage>
                <lpage>114</lpage>
                <pub-id pub-id-type="pmid">21112411</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.yuwaiman.2009.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Inherited mitochondrial optic neuropathies.</article-title>
                <source>J Med Genet.</source>
                <volume>46</volume>
                <fpage>145</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">19001017</pub-id>
              </element-citation>
            </ref>
            <ref id="lhon.REF.zanna.2005.997">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zanna</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Porcelli</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinuzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rugolo</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Caspase-independent death of Leber's hereditary optic neuropathy cybrids is driven by energetic failure and mediated by AIF and Endonuclease G.</article-title>
                <source>Apoptosis</source>
                <volume>10</volume>
                <fpage>997</fpage>
                <lpage>1007</lpage>
                <pub-id pub-id-type="pmid">16151635</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="lhon.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="lhon.Suggested_Reading.reflist0">
            <ref id="lhon.REF.yuwaiman.2014.521">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yu-Wai-Man</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Votruba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>Treatment strategies for inherited optic neuropathies: past, present and future.</article-title>
                <source>Eye.</source>
                <year>2014</year>
                <volume>28</volume>
                <fpage>521</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">24603424</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="lhon.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="lhon.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>23 June 2016 (ma) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 September 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 April 2012 (cd/pc) Revision: prenatal testing no longer listed in GeneTests Laboratory Directory; addition to <xref ref-type="sec" rid="lhon.Therapies_Under_Investigation">therapies</xref> (EPI-743)</p>
            </list-item>
            <list-item>
              <p>7 July 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>10 March 2008 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>3 October 2005 (pc) Revision: mitochondrial gene MTND2 added</p>
            </list-item>
            <list-item>
              <p>12 April 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>7 March 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 January 2002 (pc) Author revisions</p>
            </list-item>
            <list-item>
              <p>27 August 2001 (pc) Author revisions</p>
            </list-item>
            <list-item>
              <p>26 October 2000 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>May 2000 (pc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
